SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern - eBioMedicine

2022-09-24 03:18:04 By : Mr. sunny zhen

If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

Please enter a term before submitting your search.

Hansen CH, Friis NU, Bager P, et al. Risk of reinfection, vaccine protection, and severity of infection with the BA.5 Omicron subvariant: a Danish Nation-Wide Population-Based Study. 2022. Available at SSRN: https://ssrn.com/abstract=4165630 or https://doi.org/10.2139/ssrn.4165630.

Hansen CH, Friis NU, Bager P, et al. Risk of reinfection, vaccine protection, and severity of infection with the BA.5 Omicron subvariant: a Danish Nation-Wide Population-Based Study. 2022. Available at SSRN: https://ssrn.com/abstract=4165630 or https://doi.org/10.2139/ssrn.4165630.

DOI: https://doi.org/10.1016/j.ebiom.2022.104270

Permitted For non-commercial purposes: Read, print & download Redistribute or republish the final article Text & data mine Translate the article (private use only, not for distribution) Reuse portions or extracts from the article in other works Not Permitted Sell or re-use for commercial purposes Distribute translations or adaptations of the article Elsevier's open access license policy

COVID-19 Resource Centre Access the latest 2019 novel coronavirus disease (COVID-19) content from across The Lancet journals as it is published.

We use cookies to help provide and enhance our service and tailor content and ads. To update your cookie settings, please visit the Cookie Preference Center for this site. Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals. Privacy Policy   Terms and Conditions   Accessibility